AI-Mind has now concluded
The AI-Mind project officially finished at the end of February 2026. Over the course of the project, the consortium developed and validated AI-based digital tools designed to support earlier dementia risk assessment and help healthcare professionals identify people with Mild Cognitive Impairment who may be at higher risk of developing dementia. Read more.
What is the challenge?
There are over 50 million people worldwide living with dementia, and this number is expected to reach 82 million by 2030.
As the brain ages, it becomes more vulnerable to decline, and maintaining independence in daily life can become increasingly challenging for older adults. People with Mild Cognitive Impairment, an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.
There remains an urgent need for early risk assessment and timely intervention. Current clinical practices often involve time-consuming patient investigations and tend to focus on managing later-stage symptoms, partly due to the limited availability of diagnostic tools. This creates significant implications for families, healthcare systems and care costs.
Through AI-Mind, the consortium worked to reduce the burden of dementia by developing novel, AI-based tools to support healthcare professionals in diagnosis and enable more timely interventions for patients.
At the heart of AI-Mind was our research study, that
Took place in Norway, Finland, Italy and Spain and involved 1,000 participants.
Helped to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.
For more information, please visit the local study pages by clicking the box below
Go to AI-Mind Share
A space designed to share valuable insights from the AI-Mind project and our research. Here, you will find resources on dementia research, MCI diagnosis, AI in healthcare, data privacy, and more.
Click hereArchive (project news)

The AI-Mind project has come to a close
After five years of collaborative research, the AI-Mind project, funded by Horizon 2020, came to an end in February 2026. Bringing together 17 partners across 8 European countries, the project set out to develop artificial intelligence (AI) tools for screening brain connectivity and dementia risk estimation.

AI-Mind wins first-ever Award for Excellence in Clinical Trials
The AI-Mind project, a European research project developing artificial intelligence (AI)-based tools for early dementia risk prediction, has been awarded the first-ever Award for Excellence in Clinical Trials, winning the category Innovative Environment of the Year.
AI-Mind
-
External advisors from ethics, neuroscience, AI, modelling and economics
-
Advocacy groups for patients and physicians